XRAY - DENTSPLY SIRONA Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
57.09
+0.16 (+0.28%)
At close: 4:00PM EDT

57.09 0.00 (0.00%)
After hours: 4:41PM EDT

Stock chart is not supported by your current browser
Previous Close56.93
Open56.77
Bid57.05 x 1100
Ask57.61 x 1800
Day's Range56.68 - 57.19
52 Week Range33.93 - 59.40
Volume986,090
Avg. Volume1,667,541
Market Cap13.358B
Beta (3Y Monthly)0.73
PE Ratio (TTM)N/A
EPS (TTM)-4.72
Earnings DateAug 2, 2019
Forward Dividend & Yield0.35 (0.61%)
Ex-Dividend Date2019-06-27
1y Target Est59.00
Trade prices are not sourced from all markets
  • Will Abbott's (ABT) Q2 Earnings Gain From Overall Growth?
    Zacks11 hours ago

    Will Abbott's (ABT) Q2 Earnings Gain From Overall Growth?

    Abbott's (ABT) consistent rise on a strong Diabetes Care business performance is seen over the last few quarters.

  • McKesson (MCK) to Report Q1 Earnings: What's in the Offing?
    Zacks12 hours ago

    McKesson (MCK) to Report Q1 Earnings: What's in the Offing?

    Top-line growth and better-than-expected segmental performance are likely to aid McKesson (MCK) in Q1. However, rise in adjusted operating expenses is likely to be a dampener.

  • Can Instruments Drive Intuitive Surgical (ISRG) Q2 Earnings?
    Zacks4 days ago

    Can Instruments Drive Intuitive Surgical (ISRG) Q2 Earnings?

    Intuitive Surgical (ISRG) expects its core Instruments and Accessories unit to boost second-quarter 2019 results.

  • GlobeNewswire5 days ago

    Dentsply Sirona to Host Second Quarter 2019 Conference Call on August 2nd

    CHARLOTTE, N.C., July 11, 2019 -- DENTSPLY SIRONA Inc. (NASDAQ:XRAY), The Dental Solutions Company™, today announced that the Company will host an investor conference call and.

  • AngioDynamics (ANGO) Q4 Earnings Miss, Revenues Top Estimates
    Zacks5 days ago

    AngioDynamics (ANGO) Q4 Earnings Miss, Revenues Top Estimates

    AngioDyamics (ANGO) gains from solid segmental contributions in fourth-quarter fiscal 2019.

  • Markit7 days ago

    See what the IHS Markit Score report has to say about DENTSPLY SIRONA Inc.

    DENTSPLY SIRONA Inc NASDAQ/NGS:XRAYView full report here! Summary * ETFs holding this stock are seeing positive inflows but are weakening * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for XRAY with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting XRAY. Money flowETF/Index ownership | NegativeETF activity is negative and may be weakening. The net inflows of $2.98 billion over the last one-month into ETFs that hold XRAY are among the lowest of the last year and appear to be slowing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Barrons.com8 days ago

    Cardinal Health Stock Dips on News of Departure of CFO Jorge Gomez

    Monday started with a jolt for investors in the pharmaceutical distributor, which announced in a regulatory filing that longtime Chief Financial Officer Jorge Gomez is leaving the company.

  • MarketWatch8 days ago

    Dentsply Sirona says Cardinal Health CFO Jorge Gomez to become its CFO

    Dental products maker Dentsply Sirona Inc. said Monday it has appointed Jorge Gomez, former chief financial officer of Cardinal Health Inc. as its CFO. The announcement came shortly after Cardinal Health said Gomez was leaving on Aug. 9. Dentsply shares were not active premarket, but have gained 55% in 2019, while the S&P 500 has gained 19.3%.

  • GlobeNewswire8 days ago

    Dentsply Sirona Announces Appointment of Jorge M. Gomez as Chief Financial Officer

    DENTSPLY SIRONA Inc. (“Dentsply Sirona”) (XRAY), the Dental Solutions Company, today announced the appointment of Jorge M. Gomez as Chief Financial Officer. Jorge M. Gomez served as Chief Financial Officer of Cardinal Health since January 2018, where he was responsible for financial activities across the enterprise, including financial strategy, capital deployment, treasury, investor relations, tax, accounting and external reporting.  Prior to that, Jorge was Chief Financial Officer of the Medical and Pharmaceutical segments, and Treasurer and Corporate Controller at Cardinal Health.  Before joining Cardinal Health, Jorge held multiple executive and leadership roles at General Motors and the Smurfit-Kappa Group. "On behalf of the entire management team, I would like to extend a warm welcome to Jorge Gomez.  He is a talented global executive with an in-depth knowledge of the healthcare market, who brings the right mix of skills and experience, and a solid track record of successfully managing global finance operations,” said Don Casey, Dentsply Sirona’s CEO.

  • Smith & Nephew Acquires Atracsys, Expands Robotic Portfolio
    Zacks12 days ago

    Smith & Nephew Acquires Atracsys, Expands Robotic Portfolio

    With Smith & Nephew's (SNN) buyout of Atracsys, the latter's fusionTrack 500 optical tracking camera will be a core enabling technology for the company's next-generation robotics platform.

  • Varian to Acquire Boston Scientific's Embolic Bead Products
    Zacks13 days ago

    Varian to Acquire Boston Scientific's Embolic Bead Products

    Varian (VAR) expects the buyout to prove accretive to its fiscal 2020 reported and adjusted earnings per share.

  • Myriad Genetics' Elevate 2020 Plan Holds Promise Amid Issues
    Zacks14 days ago

    Myriad Genetics' Elevate 2020 Plan Holds Promise Amid Issues

    Myriad Genetics (MYGN) unveils an 'Elevate 2020' program that aims to generate $50 million in incremental operating income by fiscal 2020.

  • Medtronic's Titan Spine Buyout to Boost Spine Surgery Range
    Zacks14 days ago

    Medtronic's Titan Spine Buyout to Boost Spine Surgery Range

    Medtronic's (MDT) comprehensive biologics portfolio clubbed with Titan Spine's surface-enhanced titanium implants can enhance patient outcomes in spinal procedures.

  • Walgreens Gains on Strategic Deals, Margin Pressure Remains
    Zacks15 days ago

    Walgreens Gains on Strategic Deals, Margin Pressure Remains

    Walgreens Boots' (WBA) Retail Pharmacy USA division is witnessing comparable prescription growth and also benefiting from a strong retail prescription market.

  • Thermo Fisher's Unit Sale May Not Ail Specialty Diagnostics
    Zacks15 days ago

    Thermo Fisher's Unit Sale May Not Ail Specialty Diagnostics

    The Anatomical Pathology business of Thermo Fisher (TMO) belongs to its Specialty Diagnostics segment that serves customers across healthcare and clinical laboratories.

  • Here's Why You Should Hold Varian Medical (VAR) Stock Now
    Zacks15 days ago

    Here's Why You Should Hold Varian Medical (VAR) Stock Now

    Varian (VAR) expects the Cancer Treatment Services International buyout to prove accretive to earnings per share during fiscal 2021.

  • Amedisys Rides on New Buyouts, Strength in Personal Care Arm
    Zacks18 days ago

    Amedisys Rides on New Buyouts, Strength in Personal Care Arm

    Amedisys' (AMED) recently-integrated Personal Care segment is attaining stability and living up to expectation.

  • Veeva's Vault eTMF Implemented by South Korea's Celltrion
    Zacks18 days ago

    Veeva's Vault eTMF Implemented by South Korea's Celltrion

    Management at Veeva (VEEV) expects Vault subscription revenues to grow a significant 40% in fiscal 2020.

  • Patterson Companies' (PDCO) Earnings Miss Estimates in Q4
    Zacks19 days ago

    Patterson Companies' (PDCO) Earnings Miss Estimates in Q4

    Patterson Companies' (PDCO) Q4 results benefit from higher revenues, gross margin expansion and solid show by Animal Health segment.

  • Varian (VAR) & Tennessee Oncology to Implement Use of Noona
    Zacks19 days ago

    Varian (VAR) & Tennessee Oncology to Implement Use of Noona

    Varian's (VAR) core Oncology unit gets a boost from the latest collaboration with Tennessee Oncology.

  • Here's Why You Should Invest in DENTSPLY SIRONA (XRAY) Now
    Zacks20 days ago

    Here's Why You Should Invest in DENTSPLY SIRONA (XRAY) Now

    DENTSPLY (XRAY) focuses on innovation through active R&D.

  • Veeva's Submissions & RIM Implemented by Sumitomo Dainippon
    Zacks20 days ago

    Veeva's Submissions & RIM Implemented by Sumitomo Dainippon

    Veeva's (VEEV) flagship Vault platform witnesses robust demand.

  • Moody's22 days ago

    Dentsply Sirona Inc. -- Moody's announces completion of a periodic review of ratings of Dentsply Sirona Inc.

    Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Dentsply Sirona Inc. New York, June 24, 2019 -- Moody's Investors Service ("Moody's") has completed a periodic review of the ratings of Dentsply Sirona Inc. and other ratings that are associated with the same analytical unit. The review was conducted through a portfolio review in which Moody's reassessed the appropriateness of the ratings in the context of the relevant principal methodology(ies), recent developments, and a comparison of the financial and operating profile to similarly rated peers.

  • Here's Why You Should Buy Masimo (MASI) Stock Right Now
    Zacks22 days ago

    Here's Why You Should Buy Masimo (MASI) Stock Right Now

    Masimo (MASI) receives FDA clearance for its O3 Regional Oximetry for utilization on neonatal and infant patients.

  • What's in Store for Patterson Companies (PDCO) in Q4 Earnings?
    Zacks25 days ago

    What's in Store for Patterson Companies (PDCO) in Q4 Earnings?

    Patterson Companies (PDCO) expects to gain from the Animal Health unit in fourth-quarter fiscal 2019.